Prelude Capital Management’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.6K | Buy |
+15,700
| New | +$33.6K | ﹤0.01% | 958 |
|
|
2025
Q1 | – | Sell |
-17,499
| Closed | -$38.3K | – | 1423 |
|
|
2024
Q4 | $38.3K | Sell |
17,499
-3,501
| -17% | -$7.67K | ﹤0.01% | 1028 |
|
|
2024
Q3 | $45.8K | Buy |
21,000
+8,900
| +74% | +$19.4K | ﹤0.01% | 1112 |
|
|
2024
Q2 | $28K | Sell |
12,100
-25,300
| -68% | -$58.4K | ﹤0.01% | 1074 |
|
|
2024
Q1 | $206K | Buy |
37,400
+9,400
| +34% | +$51.7K | 0.01% | 986 |
|
|
2023
Q4 | $69.2K | Buy |
+28,000
| New | +$69.2K | ﹤0.01% | 924 |
|
|
2023
Q3 | – | Sell |
-7,746
| Closed | -$254K | – | 1252 |
|
|
2023
Q2 | $254K | Buy |
+7,746
| New | +$254K | 0.02% | 624 |
|